Your session is about to expire
← Back to Search
Contact Lens
Contact Lenses with UV/HEV-Filter for Visual Acuity
N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2-week follow-up
Awards & highlights
Study Summary
This trial uses advanced testing methods to measure the effects of a new UV/HEV filter.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2-week follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2-week follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Visual Range for Multifocal Wearers
Visual Range for Sphere Wearers
Secondary outcome measures
Brightness Perception
Motion Detection
Trial Design
6Treatment groups
Experimental Treatment
Group I: Toric TEST/CONTROLExperimental Treatment2 Interventions
Eligible subjects who are habitual wearers of soft contact lenses that receive the toric lenses will be randomized into the toric TEST/CONTROL sequence.
Group II: Toric CONTROL/TESTExperimental Treatment2 Interventions
Eligible subjects who are habitual wearers of soft contact lenses that receive the toric lenses will be randomized into the toric CONTROL/TEST sequence.
Group III: Sphere TEST/CONTROLExperimental Treatment2 Interventions
Eligible subjects who are habitual wearers of soft contact lenses that receive the sphere lenses will be randomized into the sphere TEST/CONTROL sequence.
Group IV: Sphere CONTROL/TESTExperimental Treatment2 Interventions
Eligible subjects who are habitual wearers of soft contact lenses that receive the sphere lenses will be randomized into the sphere CONTROL/TEST sequence.
Group V: Multifocal TEST/CONTROLExperimental Treatment2 Interventions
Eligible subjects who are habitual wearers of soft contact lenses that receive the multifocal lenses will be randomized into the multifocal TEST/CONTROL sequence.
Group VI: Multifocal CONTROL/TESTExperimental Treatment2 Interventions
Eligible subjects who are habitual wearers of soft contact lenses that receive the multifocal lenses will be randomized into the multifocal CONTROL/TEST sequence.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ACUVUE OASYS 1-Day
2022
N/A
~150
ACUVUE OASYS MAX 1-Day
2022
N/A
~150
ACUVUE OASYS Multifocal
2022
N/A
~150
ACUVUE OASYS MAX 1-Day Multifocal
2022
N/A
~150
ACUVUE OASYS 1-Day for Astigmatism
2022
N/A
~280
senofilcon A based contact lens (toric) with new UV/HEV filter
2022
N/A
~150
Find a Location
Who is running the clinical trial?
Johnson & Johnson Vision Care, Inc.Lead Sponsor
216 Previous Clinical Trials
25,416 Total Patients Enrolled
87 Trials studying Visual Acuity
8,631 Patients Enrolled for Visual Acuity
Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.
44 Previous Clinical Trials
4,290 Total Patients Enrolled
33 Trials studying Visual Acuity
3,660 Patients Enrolled for Visual Acuity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently wearing contact lenses that are designed to be worn for extended periods of time.You have vision problems caused by dry eyes or other eye conditions that are significant.You have a history of crossed eyes or lazy eye.You have taken part in a clinical trial for contact lenses or lens care products within the last two weeks before joining this study.
Research Study Groups:
This trial has the following groups:- Group 1: Multifocal TEST/CONTROL
- Group 2: Sphere TEST/CONTROL
- Group 3: Toric CONTROL/TEST
- Group 4: Multifocal CONTROL/TEST
- Group 5: Sphere CONTROL/TEST
- Group 6: Toric TEST/CONTROL
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it possible to participate in this medical trial?
"This trial requests 167 patients with visual acuity of 20/25 or better, aged 18 to 70 years. Necessary criteria include: wearing soft contact lenses for at least 6 hours per day, 5 days a week in the past 30 days; refraction within -1.00 and -6.00 diopters sphere (for spherical lenses); refraction within -1.50 and -4.00 diopters sphere/-0.625 and 1-625 cylinder (for toric lenses), axis 80°/90°/100° 170°/180°/10°; comprehension and signed consent form agreement; ability"
Answered by AI
Is it still possible to obtain a place in this medical experiment?
"Indications from clinicaltrials.gov suggest that the recruitment phase for this medical trial has closed; it was first posted on November 4th 2022 and last updated two weeks ago. Fortunately, there are 5 other studies actively admitting patients at present."
Answered by AI
Are any adults over the age of forty being enlisted in this investigation?
"This clinical trial requires that potential participants are at least 18 years of age and no older than 70, as outlined in the eligibility requirements."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger